Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity-Reference-Cited by-同舟云学术

Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity

Published:2015-10 Issue:4 Volume:46 Page:406-412
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Byrne Catherine J.,Egan Sean,Fennell Jérôme P.,O’Byrne Philomena,Enright Helen,Deasy Evelyn,Ryder Sheila A.,D’Arcy Deirdre M.,McHugh Johnny

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages;Pea;Clin Pharmacokinet,2004

2. Population pharmacokinetic study of teicoplanin in severely neutropenic patients;Lortholary;Antimicrob Agents Chemother,1996

3. Teicoplanin versus vancomycin for proven or suspected infection;Cavalcanti;Cochrane Database Syst Rev,2010

4. Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome;MacGowan;J Infect Chemother,1996

5. A critical review of the dosage of teicoplanin in Europe and the USA;Wilson;Int J Antimicrob Agents,1994

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necessity for higher teicoplanin doses in older adults: a multicenter prospective observational study in China;BMC Geriatrics;2024-06-04

2. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies;Advances in Therapy;2024-05-14

3. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Patients with Hematological Malignancies;2024-03-15

4. Integration of pharmacists’ knowledge into a predictive model for teicoplanin dose planning;2023-12-17

5. Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection;British Journal of Clinical Pharmacology;2023-10-21